Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Atara Biotherapeutics Stock Price (Quote) NASDAQ:ATRA
$15.12 ( -4.06% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $15.01 | $18.35 | Friday, 15th Oct 2021 ATRA stock ended at $15.12. This is 4.06% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 5.76% from a day low at $15.10 to a day high of $15.97. |
| 90 days | $11.81 | $18.35 | |
| 52 weeks | $11.81 | $28.20 |
Historical Atara Biotherapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $15.95 | $15.97 | $15.10 | $15.12 | 796 851 |
| 2021-10-14 | $15.87 | $15.98 | $15.01 | $15.76 | 1 436 826 |
| 2021-10-13 | $17.90 | $17.97 | $15.34 | $15.66 | 1 764 239 |
| 2021-10-12 | $16.97 | $18.01 | $16.81 | $17.98 | 925 210 |
| 2021-10-11 | $17.15 | $17.22 | $16.83 | $16.93 | 503 533 |
| 2021-10-08 | $17.57 | $17.57 | $16.91 | $17.05 | 547 344 |
| 2021-10-07 | $17.46 | $17.77 | $17.30 | $17.62 | 541 113 |
| 2021-10-06 | $17.05 | $17.68 | $17.05 | $17.41 | 392 752 |
| 2021-10-05 | $17.66 | $17.84 | $17.07 | $17.48 | 634 754 |
| 2021-10-04 | $17.47 | $17.93 | $17.30 | $17.45 | 895 236 |
| 2021-10-01 | $17.73 | $18.00 | $17.04 | $17.50 | 1 263 642 |
| 2021-09-30 | $17.62 | $18.35 | $17.39 | $17.90 | 799 506 |
| 2021-09-29 | $17.75 | $17.89 | $17.25 | $17.55 | 759 694 |
| 2021-09-28 | $17.40 | $18.16 | $17.28 | $17.39 | 1 606 964 |
| 2021-09-27 | $17.17 | $17.70 | $17.05 | $17.47 | 826 572 |
| 2021-09-24 | $17.05 | $17.24 | $16.91 | $17.00 | 390 862 |
| 2021-09-23 | $16.90 | $17.39 | $16.79 | $17.30 | 670 719 |
| 2021-09-22 | $16.44 | $17.07 | $16.37 | $16.79 | 893 133 |
| 2021-09-21 | $16.27 | $16.68 | $16.09 | $16.38 | 683 700 |
| 2021-09-20 | $15.47 | $16.40 | $15.47 | $16.24 | 823 733 |
| 2021-09-17 | $16.01 | $16.25 | $15.43 | $16.08 | 1 600 238 |
| 2021-09-16 | $15.88 | $16.08 | $15.47 | $15.87 | 361 938 |
| 2021-09-15 | $15.68 | $16.16 | $15.51 | $15.90 | 451 498 |
| 2021-09-14 | $16.03 | $16.05 | $15.50 | $15.66 | 630 117 |
| 2021-09-13 | $15.77 | $16.30 | $15.27 | $16.07 | 981 572 |
| 2021-09-10 | $15.09 | $15.81 | $14.75 | $15.68 | 709 877 |
| 2021-09-09 | $14.81 | $15.33 | $14.58 | $15.07 | 405 772 |
| 2021-09-08 | $15.30 | $15.30 | $14.73 | $14.90 | 368 237 |
| 2021-09-07 | $15.48 | $15.76 | $15.08 | $15.31 | 464 746 |
| 2021-09-03 | $16.00 | $16.13 | $15.54 | $15.56 | 600 562 |
| 2021-09-02 | $15.80 | $16.26 | $15.71 | $16.12 | 605 777 |
| 2021-09-01 | $14.94 | $15.84 | $14.73 | $15.69 | 734 817 |
| 2021-08-31 | $14.74 | $15.14 | $14.65 | $14.98 | 2 395 196 |
| 2021-08-30 | $14.76 | $15.18 | $14.64 | $14.73 | 834 861 |
| 2021-08-27 | $13.85 | $14.79 | $13.73 | $14.70 | 1 143 093 |
| 2021-08-26 | $13.73 | $14.13 | $13.61 | $13.87 | 410 641 |
| 2021-08-25 | $13.62 | $14.08 | $13.45 | $13.83 | 1 231 358 |
| 2021-08-24 | $13.52 | $13.57 | $13.08 | $13.56 | 423 165 |
| 2021-08-23 | $12.70 | $14.10 | $12.61 | $13.55 | 1 079 726 |
| 2021-08-20 | $11.88 | $12.89 | $11.81 | $12.63 | 691 791 |
| 2021-08-19 | $12.48 | $12.67 | $11.95 | $11.99 | 695 261 |
| 2021-08-18 | $12.68 | $12.91 | $12.36 | $12.51 | 616 805 |
| 2021-08-17 | $12.18 | $12.74 | $12.18 | $12.69 | 604 450 |
| 2021-08-16 | $12.43 | $12.63 | $12.21 | $12.41 | 358 354 |
| 2021-08-13 | $12.52 | $12.63 | $12.36 | $12.45 | 289 855 |
| 2021-08-12 | $12.55 | $12.70 | $12.40 | $12.56 | 586 632 |
| 2021-08-11 | $12.67 | $12.71 | $12.30 | $12.55 | 473 990 |
| 2021-08-10 | $13.15 | $13.66 | $12.61 | $12.74 | 1 062 291 |
| 2021-08-09 | $12.61 | $12.80 | $12.38 | $12.49 | 286 667 |
| 2021-08-06 | $12.85 | $12.93 | $12.45 | $12.64 | 427 359 |
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with severe and life-threatening diseases. Its products under development include EBV-CTL, which is Phase II clinical trials for the treatment of malignancies associated with Epstein Barr Virus (EBV), including EBV-associated post-transplant lymphoproliferative disorders; CMV-CTL that is in Phase II clinical trials for the treatme... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
